| Tag | Content |
|---|
EnhancerAtlas ID | HS176-15079 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr16:31888380-31889250 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:31888383-31888394 | CTTCCCAGAAA | - | 6.02 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_09362 | chr16:31883929-31894617 | CD14 | | SE_13313 | chr16:31887703-31889923 | CD34_Primary_RO01480 | | SE_13728 | chr16:31884583-31893275 | CD34_Primary_RO01536 | | SE_14303 | chr16:31884791-31890285 | CD34_Primary_RO01549 | | SE_18221 | chr16:31883862-31892861 | CD4p_CD25-_CD45ROp_Memory | | SE_18388 | chr16:31883165-31894840 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19230 | chr16:31884040-31892761 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59541 | chr16:31884324-31906568 | Ly3 | | SE_65001 | chr16:31884600-31890425 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTTCTTCCCA GAAACCCAGG GCACTACAAC CACTTCCATA TAGTCGCCTA CTCATTAATC 60
ATTTTAACAC TCCCCCCACC CGACAACTGG TTTTCCCCCT GTGTTTTCCT AATGTGTGGC 120
ACGCAGAGTC TCAAATCTAC CACTGTGTTC CCCCAGACTG AGGCTTGCAG TAAAATATTA 180
AGTTTCCAGT TCCTTCCCCA CATTTTATTT GATTTTGTCA AATAAAACAA ATTCAGGTTT 240
AGGTAAGAAG TTCCTTAATT CTAAAGGAGT ATTGCAATAG GGGGAAAGCA ACAGCTGTAA 300
GATCTTTGTG GATCTCAAAG GTTAGGCAGA CAAAGACTTT CTTTCACAGG GAGGAGCAAA 360
CAAGCTCAGA AGGTAGGAGG GGAAGGGCAG GATTAAGGTG CCAAAATCAG ATTCGAGATC 420
AGAGAATGTT TCACTCTGAT GTCAGCCTGT TCTTAGGAGG GGCTTAGGGA GGGGTTGAAT 480
GTTGACCAGG CTGTGAGTGT GTCAAAGTCC AGCAACCTGG AGAAAAATAC AAAGTTTTGT 540
TAAGTAGTTT ATTCTGAACA CTGAAGACAG AGCTGTTCAG CTGAGTCAGA AGGGGAATTT 600
GGAGAGTCTG TGGCTTTGTG ATGACTAAAT CAGGGAGCAT CATCGAAGTC ATAATAGGGT 660
TGTTTTTTGC AGTAGGCTGT TCTTGGAAAA CACAAAAGAT GGGGGATTTC TTTAATCACA 720
GCTATTTACC AGGTTACTGT TCCTATTTTT TCCCACTACT TTTTTTTTTG CCCTGTATGT 780
ATTTATCTCA TTTGGCTGTT CTGAACTATA TCCTTATGAT AACCTGATAA ACATAAGTAA 840
AGTGATTTGC TGAGTTATTT GAGTAGATCT 870
|
